AwardedPRTGoodsFramework agreement€458,281
IMUNOMODULADORES - DARATUMUMAB - 3 MESES
- Published
- Published 10 July 2026
Overview
Serviços de Saúde da Região Autónoma da Madeira procured daratumumab, an immunomodulatory pharmaceutical, for a three-month supply period with an estimated value of €458,280.90. The contract was awarded to Janssen Cilag Farmaceutica, Lda on 26 June 2026.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €458,281
- Procedure
- Selective
- Contract type
- Framework agreement
- Published
- 10 July 2026
Various medicinal products
Award outcome
- Awarded value
- €458,281
- Award date
- 26 June 2026
- Contract period
- — → 24 September 2026
- JANSSEN CILAG FARMACEUTICA, LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
10 July 2026
Contracting authority
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Procuring entityFunchal, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.